Logo

ACHC

Acadia Healthcare Company, Inc.

ACHC

Acadia Healthcare Company, Inc. • NASDAQ
$17.20 ▲ 0.29% (+0.05)
Market Cap $1.59 B
52w High $47.08
52w Low $14.30
Dividend Yield 0%
P/E 14.83
Volume 641.79K
Outstanding Shares 92.22M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $851.573M ▼ $701.638M ▲ $36.246M ▲ 4.256% ▲ $0.4 ▲ $124.072M ▼
Q2-2025 $869.232M ▲ $698.397M ▲ $30.127M ▲ 3.466% ▲ $0.33 ▲ $134.136M ▲
Q1-2025 $770.505M ▼ $237.717M ▼ $8.374M ▼ 1.087% ▼ $0.09 ▼ $90.738M ▼
Q4-2024 $774.238M ▼ $642.216M ▲ $32.615M ▼ 4.213% ▼ $0.36 ▼ $107.62M ▼
Q3-2024 $815.634M $638.812M $68.132M 8.353% $0.74 $166.132M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $118.693M ▼ $6.413B ▲ $3.123B ▲ $3.12B ▲
Q2-2025 $131.421M ▲ $6.308B ▲ $3.085B ▲ $3.078B ▲
Q1-2025 $91.236M ▲ $6.148B ▲ $2.974B ▲ $3.042B ▼
Q4-2024 $76.305M ▼ $5.957B ▲ $2.766B ▲ $3.074B ▲
Q3-2024 $82.145M $5.87B $2.724B $3.032B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $36.246M ▼ $73.21M ▼ $-129.755M ▲ $43.817M ▼ $-12.728M ▼ $-63.029M ▼
Q2-2025 $37.936M ▲ $133.504M ▲ $-150.783M ▲ $57.464M ▼ $40.185M ▲ $133.504M ▲
Q1-2025 $9.064M ▼ $11.477M ▼ $-183.238M ▲ $186.692M ▲ $14.931M ▲ $-163.154M ▼
Q4-2024 $32.615M ▼ $116.701M ▼ $-203.33M ▼ $80.789M ▲ $-5.84M ▼ $-86.793M ▼
Q3-2024 $68.132M $163.129M $-193.051M $34.9M $4.978M $-27.11M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
United States Facilities
United States Facilities
 $770.00M ▲$770.00M ▲$870.00M ▲$850.00M ▼

Five-Year Company Overview

Income Statement

Income Statement Acadia’s revenue has grown steadily over the past five years, showing consistent demand for its services. Operating profits have generally improved as the company has scaled, although profitability has been bumpy. In particular, there was a small net loss in 2023 that looks tied to unusual pressures or one‑off items, followed by a clear rebound in 2024. Margins have not expanded as quickly as revenue, suggesting ongoing cost pressures from staffing, reimbursement, and growth investments. Overall, the business appears solidly profitable over the cycle, but with some volatility in earnings quality from year to year.

Balance Sheet

Balance Sheet The balance sheet shows a company that has been building its equity base while managing down leverage compared with earlier years. Shareholders’ equity has trended higher, which signals accumulated retained earnings and a thicker capital cushion. Debt is still meaningful but lower than earlier peaks, implying reduced balance‑sheet risk, though not the absence of it. Cash on hand is modest relative to the size of the business, which makes access to credit lines and stable cash generation important. Assets have grown, reflecting expansion of facilities and technology, but this also means more capital tied up in a regulated, asset‑heavy business.

Cash Flow

Cash Flow Cash generation has been less smooth than the income statement might suggest. Operating cash flow was healthy in most recent years but dipped notably in the latest period, which bears watching to see if it is temporary or a trend. Free cash flow has swung between modestly positive and clearly negative, largely because of rising capital spending. The company is clearly in an investment phase, directing substantial cash into new facilities and technology upgrades. While this can support long‑term growth and efficiency, it also leaves less financial flexibility in the short term and increases reliance on continued access to financing or improved future cash flows.

Competitive Edge

Competitive Edge Acadia holds a strong niche in behavioral health as one of the largest focused providers in the United States. Its broad network of facilities, significant bed capacity, and presence across many states provide scale advantages in marketing, staffing, and negotiations with payers. The company’s specialization in behavioral services, including its large footprint in opioid treatment centers and a full continuum of care, differentiates it from more general hospital operators. Joint ventures with major health systems deepen referral channels and brand credibility. At the same time, Acadia operates in a highly regulated, labor‑intensive field with reimbursement and policy risks, so its scale is both a strength and an ongoing management challenge.

Innovation and R&D

Innovation and R&D The company is leaning into technology and process innovation in a sector that has historically lagged on this front. A sizable modernization program is rolling out electronic health records, advanced analytics, and patient engagement tools across the network. Data‑driven initiatives in areas like opioid treatment and readmission reduction suggest a push to improve outcomes and support value‑based contracts with payers. Remote monitoring and standardized clinical protocols indicate a focus on consistency and quality. Innovation here is less about traditional R&D and more about operational and clinical transformation. Execution risk remains—large IT and process changes can be disruptive—but successful implementation could widen Acadia’s edge versus slower‑moving competitors.

Summary

Acadia Healthcare combines steady long‑term revenue growth with a strong competitive position in a structurally undersupplied behavioral‑health market. Profitability has generally been solid but not perfectly smooth, with signs of margin pressure and at least one year of earnings disruption. The balance sheet has improved compared with earlier, more leveraged years, though liquidity and debt levels still need careful management. Cash flow patterns reflect a company investing heavily in new capacity and technology rather than maximizing near‑term free cash. Strategically, its scale, specialized offerings, and deepening use of data and digital tools position it well, but reimbursement dynamics, staffing costs, and flawless execution on large technology and expansion projects remain key areas of risk and uncertainty.

NEWS

November 10, 2025 · 11:24 AM UTC

Acadia Healthcare to Participate in UBS 2025 Global Healthcare Conference

Read more

November 5, 2025 · 4:05 PM UTC

Acadia Healthcare Reports Third Quarter 2025 Results

Read more

October 20, 2025 · 4:22 PM UTC

Acadia Healthcare Announces Date for Third Quarter 2025 Earnings Release

Read more

October 7, 2025 · 4:15 PM UTC

Acadia Healthcare Appoints Todd Young as Chief Financial Officer

Read more

October 1, 2025 · 4:59 PM UTC

Khrom Capital Sends Letter to Board of Directors of Acadia Healthcare

Read more